Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study

NCT01235377 is registered in ClinicalTrials.gov with VA Pharmacy Benefits Management Strategic Healthcare Group as lead sponsor.

NCT NCT01235377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01235377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance to Target Doses of Thiazides in Actual Practice: A Feasibility Study
Lead sponsor
VA Pharmacy Benefits Management Strategic Healthcare Group
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
February 28, 2014
Enrollment
20 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension